Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Novo Nordisk says Wegovy approved in China for MASH
Novo Nordisk said Wegovy has been approved in China for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), described as the first GLP-1 RA class of drugs for that indication in the country.
Novo Nordisk says Wegovy approved in China for MASH
Novo Nordisk said Wegovy has been approved in China as the first and only GLP-1 RA for the treatment of MASH.